Page 23 - Anjali Singh

Sun Pharma's unit Taro to acquire 100% stake in Antibe Therapeutics

The acquisition is expected to be completed before March 7, 2025, subject to approval from the Ontario Superior Court of Justice

Tata Motors integrates artificial intelligence for vehicle safety

Company adopting a comprehensive approach that addresses safety before, during, and after accidents

Ceat Q3FY25 results: Net profit skids 46.4% to Rs 97.1 cr, revenue up 11.3%

Ceat's consolidated PAT for Q3FY25 stood at Rs 97.1 crore, while revenue from operations came in at Rs 3,299.9 crore

Jaguar Land Rover, Tata Comm partner to drive smarter connected cars

Through the Tata Communications MOVE platform, JLR aims to enhance its connected vehicle ecosystem, transforming the driving experience for customers worldwide

Tata Motors, Hyundai launch new variants of old cars in Jan to boost sales

The footfall only picks up in the second half of January after festivals like Makar Sankranti and Pongal

Gautam Singhania-backed SCCG seeks licence to restore foreign cars

SCCG claimed that labour costs in India are considerably lower than in countries like the UK, where restoration can cost upwards of £100-£200 per hour

USC seeks Indian collaborations to address healthcare challenges

India's efficient research systems and diverse population offer valuable opportunities for conducting impactful clinical trials

Tata Motors Group reports 1% growth in Q3 FY25 global wholesales

Global wholesales of Tata Motors' commercial vehicles, including the Tata Daewoo range, reached 97,535 units, reflecting a decline of 1 per cent compared to Q3 FY24

Lupin receives US FDA tentative approval for Ivacaftor Oral Granules

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral Granules

Three-wheeler exports rebound in 2024 despite global economic challenges

This positive trend comes after consecutive years of decline, with exports falling by 26 per cent in FY23 and 17 per cent in FY24

Hyundai introduces new variants, features upgrades for popular models

The new offerings come at a time when Hyundai has recorded its highest-ever yearly domestic sales of 6,05,433 units

Lupin gets clearance from USFDA for its Pithampur manufacturing facility

Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets

Auto component companies focus on new markets, products as growth slows

According to a recent CRISIL report, while replacement demand will provide some support, export growth is expected to taper compared to the previous year

Two-wheeler sales a mixed bag in December, stay on growth path in 2024

Manufacturers like Royal Enfield, Suzuki saw double-digit rise in sales last month

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

According to a regulatory filing with BSE, the agreement was signed on December 31, 2024, with the transaction expected to be completed by January 31, 2025

Electric two wheelers, premium bikes set to dominate market in 2025

Honda is expecting to kick off January 2025 with the highly anticipated launch of Activa e: and QC1 electric scooters

Lupin acquires Huminsulin from Lilly to strengthen diabetes portfolio

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and children

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Recent USFDA data reveals a decline in the number of adverse classification outcomes of inspections

Akums Group signs 200 million euro deal for European market expansion

The commercial supply of these products is expected to begin in 2027 and continue until 2032

Improved efficiency, demand help hospital chains make gains in 2024

Average revenue per occupied bed of major health care companies grows